Charithani B Keragala Selected Research

Charithani B Keragala Research Topics

4	Stroke (Strokes) 08/2023 - 01/2019
3	Inflammation (Inflammations) 09/2023 - 01/2019
3	Hemorrhage 09/2023 - 01/2021
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 08/2023 - 01/2021
2	Thrombosis (Thrombus) 03/2021 - 01/2021
2	Wounds and Injuries (Trauma) 01/2021 - 01/2018
2	Infections 01/2021 - 01/2019
2	Ischemic Stroke 01/2020 - 01/2020
1	Thrombocytopenia (Thrombopenia) 11/2023
1	Brain Ischemia (Cerebral Ischemia) 01/2020
1	COVID-19 01/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019
1	Sepsis (Septicemia) 01/2018
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2018
1	Thrombotic Microangiopathies 01/2018
1	Atherosclerosis 01/2018

8	Fibrinolysin FDA Link 09/2023 - 01/2019
3	PlasminogenIBA 11/2023 - 01/2019
3	Tranexamic Acid (AMCA)FDA Link 08/2023 - 01/2021
2	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2023 - 01/2020
2	Lysine (L-Lysine)FDA Link 09/2023 - 04/2021
2	Amyloid (Amyloid Fibrils)IBA 08/2023 - 01/2021
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 04/2021 - 01/2021
1	COVID-19 VaccinesIBA 11/2023
1	VaccinesIBA 11/2023
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2023
1	estropipate (Ogen)FDA LinkGeneric 09/2023
1	Proteins (Proteins, Gene)FDA Link 09/2023
1	Cell Surface ReceptorsIBA 09/2023
1	Amyloid beta-PeptidesIBA 08/2023
1	Biomarkers (Surrogate Marker)IBA 08/2023
1	FibrinIBA 03/2021
1	Hemostatics (Antihemorrhagics)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2018

1	Ligation 08/2023
1	Thrombolytic Therapy 01/2020